New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-25
DOI
10.1038/s41598-018-20281-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained ClinicallyHighlights
- (2016) Jian Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
- (2016) Marianne Benn et al. EUROPEAN HEART JOURNAL
- Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)
- (2016) Sandy Elbitar et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation
- (2016) Delia Susan-Resiga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease
- (2016) Barbara Sjouke et al. Journal of Clinical Lipidology
- Familial defective apolipoprotein B-100: A review
- (2016) Lars H. Andersen et al. Journal of Clinical Lipidology
- Characterization of Autosomal Dominant Hypercholesterolemia Caused byPCSK9Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyCLINICAL PERSPECTIVE
- (2015) Paul N. Hopkins et al. Circulation-Cardiovascular Genetics
- Exome Sequencing in Suspected Monogenic DyslipidemiasCLINICAL PERSPECTIVE
- (2015) Nathan O. Stitziel et al. Circulation-Cardiovascular Genetics
- Characterization of Autosomal Dominant Hypercholesterolemia Caused byPCSK9Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyCLINICAL PERSPECTIVE
- (2015) Paul N. Hopkins et al. Circulation-Cardiovascular Genetics
- Exome Sequencing in Suspected Monogenic DyslipidemiasCLINICAL PERSPECTIVE
- (2015) Nathan O. Stitziel et al. Circulation-Cardiovascular Genetics
- Living the PCSK9 Adventure: from the Identification of a New Gene in Familial Hypercholesterolemia Towards a Potential New Class of Anticholesterol Drugs
- (2014) Marianne Abifadel et al. Current Atherosclerosis Reports
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing
- (2014) C. Maglio et al. JOURNAL OF INTERNAL MEDICINE
- Whole exome sequencing of familial hypercholesterolaemia patients negative forLDLR/APOB/PCSK9mutations
- (2014) Marta Futema et al. JOURNAL OF MEDICAL GENETICS
- Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy
- (2013) Stefano Bertolini et al. ATHEROSCLEROSIS
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia
- (2013) Ana Catarina Alves et al. HUMAN MOLECULAR GENETICS
- Identification and biochemical analysis of a novelAPOBmutation that causes autosomal dominant hypercholesterolemia
- (2013) Ellen R. A. Thomas et al. Molecular Genetics & Genomic Medicine
- Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor
- (2012) Hua Sun et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia
- (2012) Mohammad Mahdi Motazacker et al. EUROPEAN HEART JOURNAL
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del Mutation
- (2012) Marie Marduel et al. HUMAN MUTATION
- A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases
- (2012) Miao-Xin Li et al. NUCLEIC ACIDS RESEARCH
- Exome sequencing as a tool for Mendelian disease gene discovery
- (2011) Michael J. Bamshad et al. NATURE REVIEWS GENETICS
- Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France
- (2010) Marie Marduel et al. HUMAN MUTATION
- A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100
- (2010) A. Taylor et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation
- (2009) Steve Poirier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A new method for measurement of total plasma PCSK9: clinical applications
- (2009) Geneviève Dubuc et al. JOURNAL OF LIPID RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now